NEBULA (clinical trial - PsiOxus Therapeutics Ltd) Logo Design Contest

NEBULA (clinical trial - PsiOxus Therapeutics Ltd) has selected their winning logo design.

For $475 they received 161 designs from 38 different designers from around the world.
Contest
Logo Design Brief Edit  Hide
lball
United Kingdom

Slogan

please see the Ideas tab for further information

What We Do

PsiOxus aims to be the world’s leading company in tumour re-engineering, delivering medicines of value to patients with cancer.
PsiOxus is a clinical stage company pioneering systemic oncology products that drive reprogramming of the tumor microenvironment to overcome the central challenge of resistance to therapy. We have a rapidly expanding pipeline of novel monotherapy and combination products to dramatically improve outcomes for patients with cancer.

Target audience: Medical professionals and patients

Industry

Medical

Color Preferences

Purple, grey, green, white

Our Ideas and Additional Information:

We'd like a logo designed for our new clinical trial called 'NEBULA' (Mechanism of Action of Transgene in epithelial tumour Study).

We'd like the NEBULA logo to be of a similar style to the Star and Fortitude logos with the aim of creating a consistent portfolio style

Themes

Simple
Modern
Refined
Secure

Style Inspiration

Entries
Order by Ranking Entry Number

Contest Entries

Order by Ranking Entry Number
1st  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  
Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  

Withdrawn

Prefers others.  
1 2 3 4